tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Nathan Weinstein, 38 are a BUY (92.68%), 3 are a HOLD (7.32%).
Analyst Nathan Weinstein, currently employed at CITI, carries an average stock price target met ratio of 30.39% that have a potential upside of 16.95% achieved within 48 days.
Nathan Weinstein’s has documented 68 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EVGN, Evogene at 12-Sep-2022.
Analyst best performing recommendations are on AMRN (AMARIN PLC).
The best stock recommendation documented was for AMRN (AMARIN PLC) at 10/31/2019. The price target of $460 was fulfilled within 15 days with a profit of $131.6 (40.07%) receiving and performance score of 26.72.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-Jul-2021
$14
$10.61 (312.98%)
$11
4 months 14 days ago
(22-Oct-2025)
0/5 (0%)
$8.36 (148.23%)
Buy Since 18-Oct-2021
$15
$11.61 (342.48%)
$15
5 months 13 days ago
(23-Sep-2025)
0/7 (0%)
$9.39 (167.38%)
Buy Since 13-Jul-2021
1 years 8 months 15 days ago
(21-Jun-2024)
0/1 (0%)
$26.23 (139.74%)
Buy Since 13-Jul-2021
$9
$5.61 (165.49%)
2 years 9 months 24 days ago
(12-May-2023)
0/3 (0%)
$7.1 (373.68%)
Buy Since 12-Nov-2021
2 years 11 months 9 days ago
(27-Mar-2023)
0/1 (0%)
$17.08 (114.48%)
What Year was the first public recommendation made by Nathan Weinstein?
